Newsletter | August 3, 2026

08.03.26 -- Patients Should Shape Trials Before Protocols Are Finalized

PATIENT CENTRICITY

Patients Should Shape Trials Before Protocols Are Finalized

Leida Bowen explains how patient councils and early input can inform protocol design, reduce burden, and ensure trials reflect patient needs before study execution begins.

Best-In-Class Solutions Accelerate Development Of GLP-1 Therapeutics

As metabolic trials expand, success hinges on mitigating participant fatigue, offering culturally tailored dietary support, and designing inclusive protocols to retain a truly diverse cohort.

Trusted RTSM, Powered By Exceptional People

Purpose‑driven work, deep experience, and strong values help life‑changing therapies reach patients faster through empathy, collaboration, and quality across life sciences.

Advancing Research With Precision, Partnership, And Patient Focus

You can improve your neuromuscular and neurodegenerative trial's recruitment, retention, and satisfaction by aligning trial design with patient and caregiver needs using a 360° patient-centric model.

PATIENT RECRUITMENT

Education Is Essential To Representative Enrollment

According to Leida Bowen, the biggest challenge with inclusive trials is often education, helping colleagues and stakeholders better understand patient disparities and experiences so they can avoid unintentionally creating barriers to participation.

AI-Powered Strategy Is Redefining Patient Recruitment Performance

This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

How Community Engagement Drives Better Study Outcomes

Examples of how embedded community sites and local events show how authentic on‑the‑ground involvement translates into deeper patient relationships and measurable study outcomes.

CLINICAL SITES

Why The Governed Hybrid Site Model Is Strategically Superior — Part 3

In the third and final part of this series, Paradigm Clinical Research CEO Kurt Mussina, who's become an advocate for the governed hybrid platform, explains why he believes it's the best fit for sponsors.

Where The Data Starts: Rebuilding Sponsor-Site Alignment On Source

In this candid discussion, we cover the disconnect between sponsor-designed data systems and the way source data is actually created, managed, and verified at the site.

European Clinical Trial Support Has To Work Country By Country

Cross-border trial access looks easy in policy, but patients face real barriers: travel, documents, reimbursement, language. Plan the support model before recruitment begins so patients can participate.

Why Should Site Agility Be Your Next Competitive Advantage?

Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical SitesPatient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: